Dendritic cell differentiation induced by a self-peptide derived from apolipoprotein E

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 6859-6871

  Stephens, Tracey A ^a   Nikoopour, Enayat ^a   Rider, Beverly J ^a   Leon Ponte, Matilde ^a   Chau, Thu A ^b   Mikolajczak, Sebastian ^a   Chaturvedi, Pratibha ^a   Lee Chan, Edwin ^a   Flavell, Richard A ^c   Haeryfar, S M Mansour ^a   Madrenas, Joaquin ^a,b   Singh, Bhagirath ^a,b,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; B7 ANTIGEN; CD86 ANTIGEN; EP1.B PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; APOLIPOPROTEIN E (239 252), MOUSE; APOLIPOPROTEIN E (239-252), MOUSE; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIGEN PRESENTATION; ARTICLE; BAGG ALBINO MOUSE; C3H MOUSE; C57BL 6 MOUSE; CELL ADHESION; CELL AGGREGATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MICROSCOPY; MONOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN CELL; ANIMAL; CELL LINE; CYTOLOGY; IMMUNOLOGY; MIXED LYMPHOCYTE CULTURE; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 58149189056     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.6859     Document Type: Article

References (62)

1. Ueno, H., E. Klechevsky, R. Morita, C. Aspord, T. Cao, T. Matsui, P. T. Di, J. Connolly, J. W. Fay, V. Pascual, et al. 2007. Dendritic cell subsets in health and disease. Immunol. Rev. 219: 118-142. (Pubitemid 47393528)
2. Steinman, R. M. 2007. Dendritic cells: versatile controllers of the immune system. Nat. Med. 13: 1155-1159. (Pubitemid 47530635)
3. Mayordomo, J. I., T. Zorina, W. J. Storkus, L. Zitvogel, C. Celluzzi, L. D. Falo, C. J. Melief, S. T. Ildstad, W. M. Kast, A. B. DeLeo, et al. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1: 1297-1302.
4. Steptoe, R. J., and A. W. Thomson. 1996. Dendritic cells and tolerance induction. Clin. Exp. Immunol. 105: 397-402.
5. Link, H., Y. M. Huang, T. Masterman, and B. G. Xiao. 2001. Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis. J. Neuroimmunol. 114: 1-7. (Pubitemid 32184719)
6. McCurry, K. R., B. L. Colvin, A. F. Zahorchak, and A. W. Thomson. 2006. Regulatory dendritic cell therapy in organ transplantation. Transpl. Int. 19: 525-538. (Pubitemid 43881752)
7. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204: 191-201.
8. Tacke, F., and G. J. Randolph. 2006. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211: 609-618. (Pubitemid 44241645)
9. Naik, S. H., D. Metcalf, A. van Nieuwenhuijze, I. Wicks, L. Wu, M. O'Keeffe, and K. Shortman. 2006. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7: 663-671.
10. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7: 19-30.
11. + splenic dendritic cells. Blood 103: 2668-2676.
12. Leon, B., M. Lopez-Bravo, and C. Ardavin. 2005. Monocyte-derived dendritic cells. Semin. Immunol. 17: 313-318.
13. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor α: II. Functional analysis. Blood 90: 1458-1470.
14. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118. (Pubitemid 24091769)
15. Ardavin, C., G. Martinez del Hoyo, P. Martin, F. Anjuere, C. F. Arias, A. R. Marin, S. Ruiz, V. Parrillas, and H. Hernandez. 2001. Origin and differentiation of dendritic cells. Trends Immunol. 22: 691-700.
16. Menetrier-Caux, C., M. C. Thomachot, L. Alberti, G. Montmain, and J. Y. Blay. 2001. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells. Cancer Res. 61: 3096-3104. (Pubitemid 32691960)
17. Hanada, K., R. Tsunoda, and H. Hamada. 1996. GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity. J. Leukocyte Biol. 60: 181-190. (Pubitemid 26301001)
18. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184: 1953-1962. (Pubitemid 26404485)
19. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96: 1036-1041. (Pubitemid 129660276)
20. Hart, D. N. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90: 3245-3287.
21. Schreurs, M. W., A. A. Eggert, A. J. de Boer, C. G. Figdor, and G. J. Adema. 1999. Generation and functional characterization of mouse monocyte-derived dendritic cells. Eur. J. Immunol. 29: 2835-2841.
22. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
23. Ishigami, M., D. K. Swertfeger, N. A. Granholm, and D. Y. Hui. 1998. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J. Biol. Chem. 273: 20156-20161. (Pubitemid 28377573)
24. Kelly, M. E., M. A. Clay, M. J. Mistry, H. M. Hsieh-Li, and J. A. Harmony. 1994. Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. Cell. Immunol. 159: 124-139.
25. Okano, Y., M. Macy, A. D. Cardin, and J. A. Harmony. 1985. Suppression of lymphocyte activation by plasma lipoproteins: modulation by cell number and type. Exp. Cell Biol. 53: 199-212. (Pubitemid 15036717)
26. Pepe, M. G., and L. K. Curtiss. 1986. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. J. Immunol. 136: 3716-3723.
27. Vogel, T., N. H. Guo, R. Guy, N. Drezlich, H. C. Krutzsch, D. A. Blake, A. Panet, and D. D. Roberts. 1994. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J. Cell. Biochem. 54: 299-308. (Pubitemid 24097226)
28. Ishibashi, S., J. Herz, N. Maeda, J. L. Goldstein, and M. S. Brown. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA 91: 4431-4435.
29. Westerlund, J. A., and K. H. Weisgraber. 1993. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J. Biol. Chem. 268: 15745-15750. (Pubitemid 23222075)
30. Wilson, C., M. R. Wardell, K. H. Weisgraber, R. W. Mahley, and D. A. Agard. 1991. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252: 1817-1822. (Pubitemid 21917100)
31. Hunt, D. F., H. Michel, T. A. Dickinson, J. Shabanowitz, A. L. Cox, K. Sakaguchi, E. Appella, H. M. Grey, and A. Sette. 1992. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256: 1817-1820.
32. Rider, B. J., E. Fraga, Q. Yu, and B. Singh. 1996. Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules. Mol. Immunol. 33: 625-633.
33. Zechel, M. A., P. Chaturvedi, E. C. Lee-Chan, B. J. Rider, and B. Singh. 1996. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide. J. Immunol. 156: 4232-4239. (Pubitemid 26165820)
34. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752. (Pubitemid 29314747)
35. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, H. C. Van, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088. (Pubitemid 29001265)
36. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13: 816-825.
37. McLaren, J., M. Rowe, and P. Brennan. 2007. Epstein-Barr virus induces a distinct form of DNA-bound STAT1 compared with that found in interferon-stimulated B lymphocytes. J. Gen. Virol. 88: 1876-1886. (Pubitemid 47009928)
38. Rieger-Christ, K. M., P. Lee, R. Zagha, M. Kosakowski, A. Moinzadeh, J. Stoffel, A. Ben-Ze'ev, J. A. Libertino, and I. C. Summerhayes. 2004. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway. Oncogene 23: 4745-4753.
39. Wu, W., W. L. Lee, Y. Y. Wu, D. Chen, T. J. Liu, A. Jang, P. M. Sharma, and P. H. Wang. 2000. Expression of constitutively active phosphatidylinositol 3-kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells. J. Biol. Chem. 275: 40113-40119. (Pubitemid 32064637)
40. Yu, F., J. N. Harada, H. J. Brown, H. Deng, M. J. Song, T. T. Wu, J. Kato-Stankiewicz, C. G. Nelson, J. Vieira, F. Tamanoi, et al. 2007. Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog. 3: e44. (Pubitemid 46535816)
41. Bell, D., J. W. Young, and J. Banchereau. 1999. Dendritic cells. Adv. Immunol. 72: 255-324.
42. + monocytes through distinct pathways that activate NK-κB. J. Immunol. 165: 3647-3655.
43. Vlad, G., R. Cortesini, and N. Suciu-Foca. 2005. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J. Immunol. 174: 5907-5914. (Pubitemid 40663774)
44. + progenitor cells. Exp. Hematol. 26: 489-500.
45. Choi, G. S., J. M. Kang, and M. G. Lee. 2000. Analysis of methods for the generation of dendritic cells from human peripheral blood monocytes. Yonsei Med. J. 41: 642-650.
46. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
47. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174: 6592-6597.
48. Chorny, A., E. Gonzalez-Rey, and M. Delgado. 2006. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation. Ann. NY Acad. Sci. 1088: 187-194. (Pubitemid 47092026)
49. Delgado, M., E. Gonzalez-Rey, and D. Ganea. 2005. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J. Immunol. 175: 7311-7324. (Pubitemid 41713427)
50. Zhang, W., T. Chen, T. Wan, L. He, N. Li, Z. Yuan, and X. Cao. 2000. Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways. Biochem. Biophys. Res. Commun. 274: 872-879. (Pubitemid 30663712)
51. Ardeshna, K. M., A. R. Pizzey, S. Devereux, and A. Khwaja. 2000. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 96: 1039-1046.
52. Puig-Kroger, A., M. Relloso, O. Fernandez-Capetillo, A. Zubiaga, A. Silva, C. Bernabeu, and A. L. Corbi. 2001. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 98: 2175-2182.
53. Nakahara, T., Y. Moroi, H. Uchi, and M. Furue. 2006. Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J. Dermatol. Sci. 42: 1-11. (Pubitemid 43384125)
54. Agrawal, S., A. Agrawal, B. Doughty, A. Gerwitz, J. Blenis, T. Van Dyke, and B. Pulendran. 2003. Cutting edge: Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171: 4984-4989. (Pubitemid 37432777)
55. Rescigno, M., M. Martino, C. L. Sutherland, M. R. Gold, and P. Ricciardi-Castagnoli. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188: 2175-2180. (Pubitemid 28562533)
56. Verhasselt, V., B. W. Vanden, N. Vanderheyde, F. Willems, G. Haegeman, and M. Goldman. 1999. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-κB inhibition. J. Immunol. 162: 2569-2574. (Pubitemid 29309275)
57. Luft, T., E. Rodionova, E. Maraskovsky, M. Kirsch, M. Hess, C. Buchholtz, M. Goerner, M. Schnurr, R. Skoda, and A. D. Ho. 2006. Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals. Blood 107: 4763-4769.
58. Rodionova, E., M. Conzelmann, E. Maraskovsky, M. Hess, M. Kirsch, T. Giese, A. D. Ho, M. Zoller, P. Dreger, and T. Luft. 2007. GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood 109: 1584-1592. (Pubitemid 46239592)
59. Ammon, C., K. Mondal, R. Andreesen, and S. W. Krause. 2000. Differential expression of the transcription factor NF-κB during human mononuclear phagocyte differentiation to macrophages and dendritic cells. Biochem. Biophys. Res. Commun. 268: 99-105. (Pubitemid 30116618)
60. Bocksch, L., T. Stephens, A. Lucas, and B. Singh. 2001. Apolipoprotein E: possible therapeutic target for atherosclerosis. Curr. Drug Targets Cardiovasc. Haematol. Disord. 1: 93-106.
61. Bocksch, L., B. J. Rider, T. Stephens, E. Dai, L. Liu, H. Diao, K. Viswanathan, G. Munuswamy-Ramanujam, B. Singh, and A. Lucas. 2007. C-terminal apolipoprotein E-derived peptide, Ep1.B, displays anti-atherogenic activity. Atherosclerosis 194: 116-124. (Pubitemid 47464313)
62. Schrijvers, D. M., G. R. De Meyer, A. G. Herman, and W. Martinet. 2007. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc. Res. 73: 470-480. (Pubitemid 46073944)